December 4, 2018 / 6:13 AM / 7 days ago

BRIEF-Roche Says New Venclexta/Venclyxto Data Demonstrates Deep Responses In Two Types Of Leukaemia

Dec 4 (Reuters) - Roche Holding AG:

* NEW VENCLEXTA/VENCLYXTO DATA DEMONSTRATE DEEP RESPONSES IN TWO OF MOST COMMON TYPES OF LEUKAEMIA

* NEW ANALYSES FROM PHASE III MURANO STUDY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA SHOW CONTINUED BENEFIT FROM FIXED-DURATION REGIMEN AFTER A MEDIAN FOLLOW-UP OF THREE YEARS

* UPDATED RESULTS FROM TWO STUDIES IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKAEMIA DEMONSTRATE VENCLEXTA COMBINATIONS CONTINUED HIGH RATES OF DEEP REMISSION Source text for Eikon: Further company coverage: (Reporting by Riham Alkousaa)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below